Mechanism of Action & Scientific Focus BPC-157 is a synthetic pentadecapeptide composed of 15 amino acids
Mast Cell Activation Syndrome Treatment Conventional treatment for mast cell activation syndrome generally involves the use of pharmaceutical and over-the-counter medications to alleviate symptoms, such as the following medications: Epinephrine (such as an EpiPen) for severe reactions First generation H1 blockers diphenhydramine (Benadryl) and hydroxyzine (Vistaril) Second generation H1 blockers, including loratadine (Claritin), cetirizine (Zyrtec), and fexofenadine (Allegra) H2 blockers, such as ranitidine (Zantac) and famotidine (Pepcid) Aspirin, to block production of prostaglandin D2 and reduce flushing
Whether you're looking to recover from an injury, manage pain, or improve your overall well-being, BPC-157 can play a significant role in your recovery process
According to Sara Talpos of the science magazine Undark , a company partly owned by Sikiric sponsored a 2015 trial, at a hospital in Tijuana, that tested the safety of an oral version of BPC-157
10.1002/bem.20119 70